HPR106 Identifying Value Drivers for a Novel Treatment Targeting Core Symptoms of Autism Spectrum Disorder

Abstract

Autism Spectrum Disorder (ASD) is a highly heterogenous neurodevelopmental condition that affects communication skills, social interaction, learning skills, and behavior. There are currently no pharmacological treatments indicated for the core symptoms of ASD. Treatment often relies on patients’ access to behavioral therapy and the management of associated symptoms through off-label use of antipsychotics, SSRI's, and other medicines, which often come with significant adverse events. This research explores payer and physician perceptions of the unmet need in ASD and what stakeholders view as the most important value drivers for a potential novel treatment targeting core symptoms of ASD.